WallStSmart
IOBT

IO Biotech Inc

NASDAQ: IOBT · HEALTHCARE · BIOTECHNOLOGY

$0.05
+0.00% today

Updated 2026-04-07

Market cap
$2.32M
P/E ratio
P/S ratio
EPS (TTM)
$-1.34
Dividend yield
52W range
$0 – $3
Volume
14.5M

IO Biotech Inc (IOBT) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item201920202021202220232024
Revenue$0.00$0.00$0.00$0.00$0.00$0.00
Revenue growth (YoY)
Cost of revenue$540000.00$756000.00$849000.00
Gross profit$-540000.00$-756000.00$-849000.00
Gross margin
R&D$7.94M$8.46M$30.15M$46.99M$67.83M$71.48M
SG&A$1.98M$1.68M$11.08M$24.44M$23.61M$23.69M
Operating income$-9.91M$-10.14M$-41.23M$-71.42M$-91.44M$-95.18M
Operating margin
EBITDA$-824000.00$-12.02M$-67.45M$-69.34M$-84.47M$-93.20M
EBITDA margin
EBIT$-10.74M$-22.27M$-67.45M$-69.88M$-85.23M$-94.05M
Interest expense$6000.00$26000.00$361000.00$302000.00$3000.00
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-10.75M$-12.04M$-67.88M$-71.46M$-86.08M$-95.49M
Net income growth (YoY)-12.0%-463.7%-5.3%-20.5%-10.9%
Profit margin

Frequently asked questions

How much free cash flow does IOBT generate?

IOBT produced $-82.39M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is IOBT's balance sheet healthy?

IOBT holds $60.03M in cash and equivalents against — in long-term debt, on $47.02M of shareholder equity. That debt is best read against the cash flow the business throws off each year.